Jeremy David Lack
Directeur/Bestuurslid bij Alcresta Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Jeremy David Lack
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium Capital Management LP (Athyrium) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Jeffrey A. Ferrell in 2008 as Athyrium Capital Management LLC and converted from a Delaware limited liability company to a Delaware limited partnership in 2015. Athyrium provides advisory services on a discretionary basis to its clients, which may include specific tailored vehicles and pooled investment vehicles intended for sophisticated investors and institutional investors.
19
| Private Company | Investment Managers | 19 |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA.
8
| Holding Company | Pharmaceuticals: Other | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jeremy David Lack via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity | |
TRIA Beauty, Inc.
TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Alnara Pharmaceuticals, Inc.
Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree | |
Stanford University | College/University | Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Private Equity Investor Analyst-Equity | |
Littlejohn & Co. LLC
Littlejohn & Co. LLC Investment ManagersFinance Littlejohn & Co. LLC (Littlejohn) is a private equity firm founded in 1996 by Angus C. Littlejohn, Jr and Michael Klein. The firm is headquartered in Greenwich, Connecticut. | Investment Managers | Private Equity Investor | |
Deer Management Co. LLC
Deer Management Co. LLC Investment ManagersFinance Deer Management Co. LLC (Bessemer Venture Partners) is a venture capital firm founded in 1911. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
University of Michigan | College/University | Undergraduate Degree | |
Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
Innovacare Us LP
Innovacare Us LP Medical/Nursing ServicesHealth Services InnovaCare, Inc. provides healthcare services. It builds physician networks with physicians, hospitals, payers, patients, and employers. The company was founded by Daniel E. Straus, Joseph D. Mark and Timothy J. O'Donnell in 2003 and is headquartered in Fort Lee, NJ. | Medical/Nursing Services | Director/Board Member | |
Moscow University | College/University | Doctorate Degree | |
Sérum International, Inc.
Sérum International, Inc. Wholesale DistributorsDistribution Services Sérum International, Inc. operates as online shoe store. It offers Birkenstock products as well as Tatami, Newalk, Papillio, Birki's, Birki kids, Birko, Birkenstock Comfort Shoes, FP by Birkenstock and Alpro lines. The company was founded in 1962 and is headquartered in Laval, Canada. | Wholesale Distributors | Director/Board Member | |
Rempex Pharmaceuticals, Inc.
Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
FHM Life Sciences VIII LLC | Corporate Officer/Principal | ||
APTINYX | Pharmaceuticals: Major | Director/Board Member | |
ALPINE IMMUNE SCIENCES, INC. | Biotechnology | Director/Board Member | |
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
Seraxis, Inc.
Seraxis, Inc. Pharmaceuticals: MajorHealth Technology Part of Seraxis Pte Ltd., Seraxis, Inc. is a biotechnology company that specializes in developing a proprietary human stem cell line, sr1423, and manufacturing process to generate pancreatic islets that mimic native islets in purity and potency. The company is based in Germantown, MD. The company has also developed the seragraft device and other tools to enable survival and function of the islet replacement therapy in immunocompetent hosts. Seraxis aims to be the first to provide diabetics a clinical solution for glucose control and complete autonomy from insulin injections. The company was founded in 2013 by William L. Rust, who has been the CEO since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Lassen Therapeutics LLC operates as a therapeutic antibody company. It discovers and develops novel medicines to treat serious unmet medical needs. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Seraxis Holdings, Inc.
Seraxis Holdings, Inc. Financial ConglomeratesFinance Seraxis Holdings, Inc. functions as an investment holding private company. The company is based in Germantown, MD. The CEO of the company is William L Rust. | Financial Conglomerates | Director/Board Member | |
Enlaza Therapeutics, Inc.
Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and aims to deliver more efficacious and safer treatments for patients. The CEO of the company is Sergio G. Duron. | Miscellaneous Commercial Services | Director/Board Member | |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
Anagram Therapeutics, Inc.
Anagram Therapeutics, Inc. Medical/Nursing ServicesHealth Services Anagram Therapeutics, Inc. provides healthcare services. The company is based in Framingham, MA. The CEO of the company is Robert Gallotto. | Medical/Nursing Services | Chairman | |
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Attovia Therapeutics
Attovia Therapeutics Medical SpecialtiesHealth Technology Attovia Therapeutics manufactures a pipeline for bio therapeutics to immune-mediated diseases including cancer. The company is based in Sacramento, CA. Attovia Therapeutics was founded by Tao Fu and Tao Fu has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 44 |
Nederland | 3 |
Rusland | 2 |
Canada | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 10 |
Finance | 7 |
Health Services | 3 |
Distribution Services | 2 |
Operationeel
Director/Board Member | 127 |
Corporate Officer/Principal | 28 |
Undergraduate Degree | 23 |
Independent Dir/Board Member | 21 |
Private Equity Investor | 20 |
Sterkste connecties
Insiders | |
---|---|
James Topper | 52 |
Stephen Kraus | 34 |
Alan Muney | 28 |
Steve Dubin | 25 |
Chris McFadden | 22 |
Todd Creech | 19 |
Jeffrey Allen Ferrell | 8 |
Sean Wang | 6 |
Alexey L. Margolin | 6 |
Hondo T. Sen | 6 |
Daniel R. Orlando | 5 |
Laurent D. Hermouet | 4 |
Niyoshi Patel | 4 |
Mark Andrew Kavulich | 4 |
Michael Tischler | 4 |
- Beurs
- Insiders
- Jeremy David Lack
- Bedrijfsconnecties